Mangalam Drugs & Organics Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 1,142.02 million compared to INR 970.26 million a year ago. Revenue was INR 1,230.23 million compared to INR 977.1 million a year ago. Net income was INR 45.28 million compared to INR 110.87 million a year ago. Basic earnings per share from continuing operations was INR 2.86 compared to INR 7 a year ago. Diluted earnings per share from continuing operations was INR 2.86 compared to INR 7 a year ago. For the six months, sales was INR 2,189.8 million compared to INR 2,006.66 million a year ago. Revenue was INR 2,283.24 million compared to INR 2,020.05 million a year ago. Net income was INR 89.44 million compared to INR 193.83 million a year ago. Basic earnings per share from continuing operations was INR 5.65 compared to INR 12.25 a year ago. Diluted earnings per share from continuing operations was INR 5.65 compared to INR 12.25 a year ago.